ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 64 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q3 2023. The put-call ratio across all filers is 0.00 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $270,527 | -6.0% | 180,351 | -0.4% | 0.00% | – |
| Q2 2023 | $287,792 | +121.0% | 181,001 | -0.3% | 0.00% | – |
| Q1 2023 | $130,244 | +23.4% | 181,549 | -0.3% | 0.00% | – |
| Q4 2022 | $105,572 | -33.2% | 182,177 | +9.6% | 0.00% | – |
| Q3 2022 | $158,000 | -19.0% | 166,291 | +2.1% | 0.00% | – |
| Q2 2022 | $195,000 | -80.4% | 162,923 | -78.5% | 0.00% | – |
| Q1 2022 | $994,000 | -28.5% | 758,580 | -4.0% | 0.00% | – |
| Q4 2021 | $1,391,000 | -26.9% | 790,397 | -9.9% | 0.00% | – |
| Q3 2021 | $1,904,000 | -41.0% | 877,139 | -4.9% | 0.00% | -100.0% |
| Q2 2021 | $3,226,000 | -66.7% | 921,899 | -6.1% | 0.00% | -50.0% |
| Q1 2021 | $9,677,000 | -15.1% | 981,369 | -6.7% | 0.00% | 0.0% |
| Q4 2020 | $11,398,000 | +4.3% | 1,051,533 | -0.9% | 0.00% | 0.0% |
| Q3 2020 | $10,929,000 | -44.8% | 1,061,065 | +11.8% | 0.00% | -60.0% |
| Q2 2020 | $19,815,000 | +153.2% | 948,956 | +18.4% | 0.01% | +150.0% |
| Q1 2020 | $7,827,000 | +1.6% | 801,199 | +19.8% | 0.00% | 0.0% |
| Q4 2019 | $7,701,000 | +122.4% | 668,551 | +5.3% | 0.00% | +100.0% |
| Q3 2019 | $3,462,000 | -51.7% | 635,156 | +5.4% | 0.00% | -50.0% |
| Q2 2019 | $7,168,000 | +126.4% | 602,804 | -0.2% | 0.00% | +100.0% |
| Q1 2019 | $3,166,000 | +66.4% | 604,307 | +0.0% | 0.00% | 0.0% |
| Q4 2018 | $1,903,000 | -48.7% | 604,268 | -1.5% | 0.00% | 0.0% |
| Q3 2018 | $3,712,000 | +20.9% | 613,552 | +5.9% | 0.00% | 0.0% |
| Q2 2018 | $3,070,000 | +430.2% | 579,244 | +480.2% | 0.00% | – |
| Q1 2018 | $579,000 | +106.0% | 99,838 | +24.3% | 0.00% | – |
| Q4 2017 | $281,000 | +44.1% | 80,350 | +50.2% | 0.00% | – |
| Q3 2017 | $195,000 | +143.8% | 53,499 | +66.0% | 0.00% | – |
| Q2 2017 | $80,000 | -86.6% | 32,231 | -85.4% | 0.00% | – |
| Q1 2017 | $595,000 | -7.9% | 220,245 | -1.1% | 0.00% | – |
| Q4 2016 | $646,000 | -29.0% | 222,695 | +0.6% | 0.00% | – |
| Q3 2016 | $910,000 | -22.4% | 221,258 | -40.3% | 0.00% | – |
| Q2 2016 | $1,172,000 | – | 370,745 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BML Capital Management, LLC | 3,915,000 | $5,872,500 | 5.39% |
| Versant Venture Management, LLC | 5,068,233 | $7,602,350 | 4.04% |
| Sonic GP LLC | 2,000,000 | $3,000,000 | 2.91% |
| COMMODORE CAPITAL LP | 10,000,000 | $15,000,000 | 1.75% |
| VR Adviser, LLC | 6,573,300 | $9,859,950 | 1.04% |
| AIGH Capital Management LLC | 1,323,985 | $1,985,977 | 0.94% |
| Newtyn Management, LLC | 1,025,000 | $1,537,500 | 0.38% |
| Worth Venture Partners, LLC | 331,668 | $497,502 | 0.30% |
| Acuitas Investments, LLC | 291,169 | $436,754 | 0.26% |
| Quinn Opportunity Partners LLC | 398,298 | $597,447 | 0.08% |